ArticleJournal for immunotherapy of cancer2018

STAT3 antisense oligonucleotide AZD9150 in a subset of patients with heavily pretreated lymphoma: results of a phase 1b trial.

Matthew J Reilley et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.